Search

Author/Creator Bargou, Ralf

4. The identification of patient‐specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild‐type melanomas. Issue 4 (18th December 2018)

Authors:
Appenzeller, Silke; Gesierich, Anja; Thiem, Alexander; Hufnagel, Anita; Jessen, Christina; Kneitz, Hermann; Regensburger, Martina; Schmidt, Cornelia; Zirkenbach, Vanessa; Bischler, Thorsten; Schilling, Bastian; Siedel, Claudia; Goebeler, Maria‐Elisabeth; Houben, Roland; Schrama, David; Gehrig, An...
Journal:
Cancer
Issue:
Volume 125:Issue 4(2019)
Page Start:
586
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma. (17th December 2014)

Authors:
Weißbach, Susann; Langer, Christian; Puppe, Bernhard; Nedeva, Theodora; Bach, Elisa; Kull, Miriam; Bargou, Ralf; Einsele, Hermann; Rosenwald, Andreas; Knop, Stefan; Leich, Ellen
Journal:
British journal of haematology
Issue:
Volume 169:Number 1(2015:Apr.)
Page Start:
57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Tumour stage distribution and survival of malignant melanoma in Germany 2002–2011. Issue 1 (December 2016)

Authors:
Schoffer, Olaf; Schülein, Stefanie; Arand, Gerlinde; Arnholdt, Hans; Baaske, Dieter; Bargou, Ralf; Becker, Nikolaus; Beckmann, Matthias; Bodack, Yves; Böhme, Beatrix; Bozkurt, Tayfun; Breitsprecher, Regine; Buchali, Andre; Burger, Elke; Burger, Ulrike; Dommisch, Klaus; Elsner, Gudrun; Fernschild,...
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗